CDKN2A-p16 Positive
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Alpelisib in Treating Participants With Transorally Resectable HPV-Associated Stage I-IVA Oropharyngeal Cancer (NCT03601507) | University of Arizona | 2019-03-11 |
Track CDKN2A-p16 Positive automatically
Every clearance here is in the API, with alerts when new ones post.